Search Videos and More
News
Paving the way for optimal LAAO procedure outcomes
WellSpan health is a national leader in left atrial appendage occlusion (LAAO) research, technology and procedures. Their aim is to reduce stroke risk in atrial fibrillation (Afib) patients who are not amenable to anticoagulation.
Video
The future of personalization: Advancing precision medicine
Health care is no longer one-size-fits-all, but a personalized journey. Advancements in technology and our understanding of human biology allow us to predict and prevent disease. Hear our WellSpan experts discuss the future of medicine.
News
Precision medicine for the people
The Gene Health Project at WellSpan Health, a partnership with Helix, will offer a new way to determine genetic risk for cardiac disease and cancer.